Why are the left-sided heart valves (mitral and aortic) preferentially affected in rheumatic heart disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Left-Sided Valves Are Preferentially Affected in Rheumatic Heart Disease

The left-sided heart valves (mitral and aortic) are preferentially affected in rheumatic heart disease because they experience higher hemodynamic pressures and mechanical stress compared to right-sided valves, making them more susceptible to the inflammatory and fibrotic processes triggered by the post-streptococcal autoimmune response.

Pathophysiological Mechanism

The preferential involvement of left-sided valves in RHD stems from the intersection of hemodynamic factors and immune-mediated injury:

Hemodynamic Stress as the Primary Factor

Left-sided valves operate under significantly higher pressure gradients than right-sided valves. The mitral valve experiences systemic left ventricular pressures, while the aortic valve faces the highest pressures in the cardiovascular system. This increased mechanical stress makes these valves more vulnerable to the inflammatory cascade initiated by molecular mimicry between Group A Streptococcal antigens and cardiac tissue 1.

Mitral Valve: The Most Affected

The mitral valve is the most commonly and severely affected valve in RHD, either alone (31.6% of cases) or in combination with other valves (52.8% of cases) 2. Despite decades of research, the exact mechanism explaining this preferential mitral involvement remains incompletely understood 1. The mitral valve shows the most extensive inflammatory infiltration, fibrosis, and calcification compared to other valves 2.

Inflammatory Pathology

The disease process involves:

  • Chronic T-helper/inducer lymphocyte infiltration in affected valves, suggesting ongoing immune-mediated injury 2
  • Progressive fibrosis leading to valve thickening, restriction, and calcification
  • Valvulitis affecting leaflet mobility and causing regurgitation through multiple mechanisms including annular dilatation, leaflet prolapse, and chordal elongation 3

Clinical Staging and Valve Involvement

According to the 2023 World Heart Federation guidelines, RHD staging specifically focuses on left-sided valve pathology 3:

  • Stage A-B (Early RHD): Mild mitral regurgitation (MR) or aortic regurgitation (AR) with morphological features
  • Stage C-D (Advanced RHD): Moderate-to-severe MR/AR, or any degree of mitral stenosis (MS)/aortic stenosis (AS)

The guidelines explicitly define pathological regurgitation in mitral and aortic valves as major criteria for carditis diagnosis, with no equivalent emphasis on right-sided valves 3.

Right-Sided Valve Involvement: Secondary and Less Common

While tricuspid valve involvement occurs in approximately 38% of cases, it is typically:

  • Less severe than left-sided disease 2
  • Often functional (secondary to pulmonary hypertension from mitral disease) rather than organic
  • Rarely isolated without concomitant left-sided involvement

Pulmonary valve involvement is exceedingly rare and not included in diagnostic criteria 3.

Key Clinical Implications

The preferential left-sided involvement means that echocardiographic screening and diagnosis should focus primarily on mitral and aortic valve assessment 3. The presence of isolated right-sided valve disease should prompt consideration of alternative diagnoses rather than RHD.

The severity hierarchy (mitral > aortic > tricuspid) guides surgical planning, as mitral valve disease typically determines clinical outcomes and intervention timing 2, 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.